Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy
about
The therapeutic potential of cannabis and cannabinoidsCannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic reviewCannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and VomitingNausea: a review of pathophysiology and therapeuticsManagement of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination ChemotherapyChemotherapy-induced nausea and vomiting: optimizing prevention and managementMarijuana Legalization: Impact on Physicians and Public HealthAntiemetic activity of N-methyllevonantradol and nabilone in cisplatin-treated catsRegulation of nausea and vomiting by cannabinoids and the endocannabinoid systemIntestinal and liver toxicity of antineoplastic drugs.A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.Nabilone: an alternative antiemetic for cancer chemotherapy.Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoid Regulation of Acute and Anticipatory Nausea.Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.Pharmacologic treatment of chemotherapy-induced nausea and vomiting.Therapeutic potential of cannabinoids.Antiemetics and cytotoxic drugsCannabinoids as antiemetics.Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes.Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
P2860
Q24600806-8F49E5D1-A505-4A60-98AC-0AE7DB463D83Q24607823-B0D9708A-FE55-42A6-8094-E6BDBE607664Q26738288-B0F1E5E3-5F04-4F2F-88DC-547DF5BAEEA7Q26771877-53735EAC-177E-4008-A18D-7389084E24FBQ26783177-1E9212EF-3E23-4595-94A7-F295E85A02EDQ26852601-5AF31E79-9588-4A6C-BBBE-296B640F6570Q28082785-4EB2D061-B9D1-44BB-97BF-C8C613B0B5C1Q28264258-78044D0D-4D4D-4CAB-A516-1AA05B6A54E8Q28301264-8153F230-835E-4CDE-92DB-0FCB4E40B1A1Q33605823-CD738725-8EED-4194-BFE5-35C62953DC48Q34013540-A729E2B5-B53C-4F29-936D-0994BD54436FQ35602855-8481E59A-6270-4DC5-8D21-80734FD61507Q35863912-382CB9C5-5100-4D14-80B5-332FC10E8836Q36048236-6D94E909-740F-4A20-85CB-BF1B35A30FDAQ37215363-EF79BEE7-B8A7-40C0-9E8E-527FA182F9FEQ37761064-C44FD889-4BF6-4623-A406-1E99D485D6AFQ38208999-10240E70-7BAA-4574-9255-11D0805010B3Q38503842-305E6D86-C783-408C-AF57-EF462E20E3A7Q38598515-50B35F74-9722-40B2-9910-14B22F5A64E5Q38943088-C4F8F415-5673-4434-9F83-83FA72E3C0DBQ38999263-3F234A13-D857-4C6F-8BF2-4074550B3792Q40030462-91F40934-6CB5-4061-AF27-05879634D678Q40078863-121BA556-03F5-4012-9356-6616EB30EC44Q42336677-6485AA10-49C7-4B26-999E-59C437E3D9E6Q42757858-8CE975EF-2143-49FE-825A-FA0FC5FDE12AQ42759375-B842DD55-8B18-4DC9-A52C-0A7AB51E61ACQ44828810-D260BC8A-5CCA-49F3-AF78-FD6B184716EBQ55333056-18BF4460-05B8-480B-8330-49C1747E98C5
P2860
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Superiority of nabilone over p ...... receiving cancer chemotherapy
@ast
Superiority of nabilone over p ...... receiving cancer chemotherapy
@en
Superiority of nabilone over p ...... receiving cancer chemotherapy
@nl
type
label
Superiority of nabilone over p ...... receiving cancer chemotherapy
@ast
Superiority of nabilone over p ...... receiving cancer chemotherapy
@en
Superiority of nabilone over p ...... receiving cancer chemotherapy
@nl
prefLabel
Superiority of nabilone over p ...... receiving cancer chemotherapy
@ast
Superiority of nabilone over p ...... receiving cancer chemotherapy
@en
Superiority of nabilone over p ...... receiving cancer chemotherapy
@nl
P2093
P3181
P1476
Superiority of nabilone over p ...... receiving cancer chemotherapy
@en
P2093
A B Chester
L H Einhorn
S D Williams
P304
P3181
P356
10.1056/NEJM197906073002302
P407
P577
1979-06-07T00:00:00Z